Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Nasmed Ozelglik Hizmetleri Ticaret AS Receivables Turnover Related Terms
Nasmed Ozelglik Hizmetleri Ticaret AS Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nasmed Ozelglik Hizmetleri Ticaret AS Receivables Turnover Chart
IST:EGEPO vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Nasmed Ozelglik Hizmetleri Ticaret AS's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nasmed Ozelglik Hizmetleri Ticaret AS Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nasmed Ozelglik Hizmetleri Ticaret AS's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Nasmed Ozelglik Hizmetleri Ticaret AS's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) has a Receivables Turnover of 2.03 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nasmed Ozelglik Hizmetleri Ticaret AS and its competitors. According to the industry distribution chart, Nasmed Ozelglik Hizmetleri Ticaret AS ranks #293 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 44.3%.
Is Nasmed Ozelglik Hizmetleri Ticaret AS's Receivables Turnover too high?
Nasmed Ozelglik Hizmetleri Ticaret AS's current Receivables Turnover is 2.03. The Healthcare Providers & Services industry median Receivables Turnover is 7.98. Nasmed Ozelglik Hizmetleri Ticaret AS's value of 2.03 is 74.6% below this industry median. Based on the distribution chart, Nasmed Ozelglik Hizmetleri Ticaret AS ranks #293 out of 662 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nasmed Ozelglik Hizmetleri Ticaret AS has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nasmed Ozelglik Hizmetleri Ticaret AS's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nasmed Ozelglik Hizmetleri Ticaret AS ranks #293 out of 662 companies for Receivables Turnover. This puts Nasmed Ozelglik Hizmetleri Ticaret AS in the upper half of its industry. The industry median Receivables Turnover is 7.98. Nasmed Ozelglik Hizmetleri Ticaret AS's value of 2.03 is 74.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.98, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nasmed Ozelglik Hizmetleri Ticaret AS's current Receivables Turnover of 2.03 is 74.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nasmed Ozelglik Hizmetleri Ticaret AS and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nasmed Ozelglik Hizmetleri Ticaret AS's current Receivables Turnover is 2.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nasmed Ozelglik Hizmetleri Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺9.38, compared to a current price of ₺16.37 — trading 74.5% above its estimated fair value. The current Receivables Turnover is 2.03 and 74.6% below the Healthcare Providers & Services industry median of 7.98. Nasmed Ozelglik Hizmetleri Ticaret AS's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO), the current Receivables Turnover is 2.03 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Overvalued in 2026?
Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS stock appears to be overvalued.
The current stock price of ₺16.37 is trading 74.5% above its estimated GF Value™ of ₺9.38.
GuruFocus considers Nasmed Ozelglik Hizmetleri Ticaret AS to be Significantly Overvalued.
Key valuation signals for IST:EGEPO:
Receivables Turnover: 2.03
GF Value™: ₺9.38 vs. price of ₺16.37 (74.5% above fair value)
Industry Position: 74.6% below the Healthcare Providers & Services median (#293 of 662)
No single metric tells the full story. See the IST:EGEPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nasmed Ozel Saglik Hizmetleri Ticaret AS provides quality healthcare services. It arranges consultations, travel planning, accommodation, translation, and other relevant services for its patients 24/7.
71GF Score
Get the complete analysis for IST:EGEPO
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:EGEPO has been successfully added to your 
